[Statins: what is their place in the treatment of chronic kidney insufficiency?]

Related Experiment Video

Updated: Jun 24, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Belén Ponte1, Vincent Bourquin, Catherine Stoermann-Chopard

  • 1Service de néphrologie, Département de médecine interne, HUG, 1211 Genève.

Revue Medicale Suisse
|March 26, 2009
PubMed

Insights

Dyslipidemia is common in chronic kidney disease (CKD) patients, increasing cardiovascular risks. Lipid-lowering drugs are recommended for secondary prevention in all CKD stages.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Pharmacology

Context:

  • Dyslipidemia is a significant issue in chronic kidney disease (CKD) patients.
  • CKD patients face elevated risks of cardiovascular morbidity and mortality.
  • The typical lipid profile in CKD includes high triglycerides, atherogenic lipoproteins, and low HDL cholesterol.

Purpose:

  • To review the role of statins in managing dyslipidemia in CKD patients.
  • To assess the efficacy and safety of lipid-lowering therapies in different stages of CKD.
  • To provide recommendations for lipid management in CKD.

Summary:

  • Statins are safe for CKD patients, similar to the general population.
  • Evidence suggests statins reduce cardiovascular mortality in predialysis CKD patients for secondary prevention.
  • Benefits in dialysis patients and primary prevention require further investigation.

Impact:

  • Highlights the cardiovascular risks associated with dyslipidemia in CKD.
  • Emphasizes the safety and potential benefits of statins in CKD management.
  • Suggests a proactive approach to lipid management in CKD patients, particularly for secondary prevention.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...